Cargando…

Neocytolysis: none, one or many? A reappraisal and future perspectives

Neocytolysis is the hypothesis formulated to explain experimental evidence of selective lysis of young red blood cells (RBCs) (neocytes) associated with decreased plasma levels of erythropoietin (EPO). In humans, it appears to take place whenever a fast RBC mass reduction is required, i.e., in astro...

Descripción completa

Detalles Bibliográficos
Autores principales: Risso, Angela, Ciana, Annarita, Achilli, Cesare, Antonutto, Guglielmo, Minetti, Giampaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924315/
https://www.ncbi.nlm.nih.gov/pubmed/24592241
http://dx.doi.org/10.3389/fphys.2014.00054
_version_ 1782303724414173184
author Risso, Angela
Ciana, Annarita
Achilli, Cesare
Antonutto, Guglielmo
Minetti, Giampaolo
author_facet Risso, Angela
Ciana, Annarita
Achilli, Cesare
Antonutto, Guglielmo
Minetti, Giampaolo
author_sort Risso, Angela
collection PubMed
description Neocytolysis is the hypothesis formulated to explain experimental evidence of selective lysis of young red blood cells (RBCs) (neocytes) associated with decreased plasma levels of erythropoietin (EPO). In humans, it appears to take place whenever a fast RBC mass reduction is required, i.e., in astronauts during the first days of spaceflight under weightlessness, where a fast reduction in plasma volume and increase in haematocrit occur. EPO plasma levels then decline and a decrease in RBC mass takes place, apparently because of the selective lysis of the youngest, recently generated RBCs (neocytes). The same process seems to occur in people descending to sea level after acclimatization at high altitude. After descent, the polycythaemia developed at high altitude must be abrogated, and a rapid reduction in the number of circulating RBCs is obtained by a decrease in EPO synthesis and the lysis of what seem to be young RBCs. In vivo, neocytolysis seems to be abolished by EPO administration. More recent research has ascribed to neocytolysis the RBC destruction that occurs under such disparate pathophysiologic conditions as nephropathy, severe obstructive pulmonary disease, blood doping, and even malaria anaemia. According to the theory, EPO's central role would be not only to stimulate the production of new RBCs in conditions of anaemia, as maintained by the orthodox view, but also that of a cytoprotective factor for circulating young RBCs. Why neocytes are specifically destroyed and how is this related to decreased EPO levels has not yet been elucidated. Changes in membrane molecules of young RBCs isolated from astronauts or mountain climbers upon return to normal conditions seem to indicate a higher susceptibility of neocytes to ingestion by macrophages. By limiting the context to space missions and high altitude expeditions, this review will address unresolved and critical issues that in our opinion have not been sufficiently highlighted in previous works.
format Online
Article
Text
id pubmed-3924315
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-39243152014-03-03 Neocytolysis: none, one or many? A reappraisal and future perspectives Risso, Angela Ciana, Annarita Achilli, Cesare Antonutto, Guglielmo Minetti, Giampaolo Front Physiol Physiology Neocytolysis is the hypothesis formulated to explain experimental evidence of selective lysis of young red blood cells (RBCs) (neocytes) associated with decreased plasma levels of erythropoietin (EPO). In humans, it appears to take place whenever a fast RBC mass reduction is required, i.e., in astronauts during the first days of spaceflight under weightlessness, where a fast reduction in plasma volume and increase in haematocrit occur. EPO plasma levels then decline and a decrease in RBC mass takes place, apparently because of the selective lysis of the youngest, recently generated RBCs (neocytes). The same process seems to occur in people descending to sea level after acclimatization at high altitude. After descent, the polycythaemia developed at high altitude must be abrogated, and a rapid reduction in the number of circulating RBCs is obtained by a decrease in EPO synthesis and the lysis of what seem to be young RBCs. In vivo, neocytolysis seems to be abolished by EPO administration. More recent research has ascribed to neocytolysis the RBC destruction that occurs under such disparate pathophysiologic conditions as nephropathy, severe obstructive pulmonary disease, blood doping, and even malaria anaemia. According to the theory, EPO's central role would be not only to stimulate the production of new RBCs in conditions of anaemia, as maintained by the orthodox view, but also that of a cytoprotective factor for circulating young RBCs. Why neocytes are specifically destroyed and how is this related to decreased EPO levels has not yet been elucidated. Changes in membrane molecules of young RBCs isolated from astronauts or mountain climbers upon return to normal conditions seem to indicate a higher susceptibility of neocytes to ingestion by macrophages. By limiting the context to space missions and high altitude expeditions, this review will address unresolved and critical issues that in our opinion have not been sufficiently highlighted in previous works. Frontiers Media S.A. 2014-02-14 /pmc/articles/PMC3924315/ /pubmed/24592241 http://dx.doi.org/10.3389/fphys.2014.00054 Text en Copyright © 2014 Risso, Ciana, Achilli, Antonutto and Minetti. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Risso, Angela
Ciana, Annarita
Achilli, Cesare
Antonutto, Guglielmo
Minetti, Giampaolo
Neocytolysis: none, one or many? A reappraisal and future perspectives
title Neocytolysis: none, one or many? A reappraisal and future perspectives
title_full Neocytolysis: none, one or many? A reappraisal and future perspectives
title_fullStr Neocytolysis: none, one or many? A reappraisal and future perspectives
title_full_unstemmed Neocytolysis: none, one or many? A reappraisal and future perspectives
title_short Neocytolysis: none, one or many? A reappraisal and future perspectives
title_sort neocytolysis: none, one or many? a reappraisal and future perspectives
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924315/
https://www.ncbi.nlm.nih.gov/pubmed/24592241
http://dx.doi.org/10.3389/fphys.2014.00054
work_keys_str_mv AT rissoangela neocytolysisnoneoneormanyareappraisalandfutureperspectives
AT cianaannarita neocytolysisnoneoneormanyareappraisalandfutureperspectives
AT achillicesare neocytolysisnoneoneormanyareappraisalandfutureperspectives
AT antonuttoguglielmo neocytolysisnoneoneormanyareappraisalandfutureperspectives
AT minettigiampaolo neocytolysisnoneoneormanyareappraisalandfutureperspectives